NSU Research Contributions

Title : ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh

Authors : Mohammad Rabiul Halim, Shuvajit Saha, Injamam Ull Haque, Sadia Jesmin, Rahatul Jannat Nishat, ASMD Ashraful Islam, Seema Roy, Miah Md Akiful Haque, Md Motiul Islam, Tarikul Hamid, Kazi Nuruddin Ahmed, Md Azharul Islam Talukder, Arif Ahmed, Emran Hasan, Nurjahan Ananna, Faroque Md Mohsin, Mohammad Delwer Hossain Hawlader

Journal Article Title: Journal of Multidisciplinary Healthcare (JMDH)	Volume Number: 14	Publication Year : 2021
Index: other (PubMed)	Ranking: No Ranking	Publisher Name: Dove Medical Press
Pages : 8

Funding Information:

Funding Source : None

Other Information:

Direct Sustainable Development Goals : SDG3 Good Health & Well-being	Indirect Sustainable Development Goals : SDG10 Reduced Inequality	Sustainable Development Sub Goals : End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases Achieve universal health coverage Substantially increase health financing and the recruitment, development and training of the health
Impact statement: This retrospective study of 771 critically ill patients in Bangladesh provides evidence that blood type A is a significant independent predictor of poor COVID-19 outcomes. Individuals with blood type A were 3.49 times more likely to die and had a higher incidence of complications such as acute kidney injury (AKI) and the need for mechanical ventilation. Conversely, blood type O was associated with fewer complications and lower mortality. These findings suggest that blood grouping should be integrated into clinical screening, allowing healthcare providers to prioritize specialized care for high-risk patients to reduce the pandemic's burden on the national health system.	Collaboration: Other	Keywords: COVID-19, ICU, ABO blood group, Bangladesh